One year after the Unite for Children. Unite against AIDS campaign, Guinea-Bissau, today launched a pediatric treatment effort against AIDS to ensure that the needs of infected and affected children are met.
The airplane leased by the Centers for Disease Control and Prevention (CDC) during public health emergencies saves lives – at a cost of one cent to each American each year. The plane plays a critical role in CDC’s ability to keep our nation safe and prepared.
A significant and largely untapped global market exists for more effective and affordable tests to diagnose tuberculosis in low and middle income countries, where most TB cases today occur.
World Health Organization (WHO) and a group of more than 25 partner organizations unveiled a new strategy to fight some of the most neglected tropical diseases that destroy the lives and health of poor people.
What’s the best treatment for a cold? Some say rest and lots of liquids, others say to feed a cold and starve a fever. But what if a person has a cold with a fever? Does medication help?
USDA’s Food Safety and Inspection Service (FSIS) has released and posted on its Web site a Public Service Announcement (PSA) to help consumers keep food safe during bad weather. “Food Safety During Power Outages,” is part of ongoing outreach efforts to raise awareness about the importance of food safety during times of power outages due to storms and other events.
Point-of-use water treatment and improved water storage reduced the incidence of diarrhea by 90 percent when compared to improved water storage alone in camps for the internally displaced in Liberia, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health. In camp settings during emergencies, diarrheal diseases have accounted for more than 40 percent of all deaths, and a majority of deaths of small children. The study evaluated Procter & Gamble’s (NYSE: PG) PUR(R) Purifier of Water and is the first to test the effectiveness of PUR under emergency conditions. It is published in the October 2006 edition of Tropical Medicine and International Health.
Three UCLA scientists will be awarded top prizes for psychiatric research on Friday by NARSAD: The Mental Health Research Association, the world’s largest donor-supported organization dedicated to funding innovative research on severe mental illnesses. Lori Altshuler, M.D.; Joaquin M. Fuster, M.D., Ph.D., and Tyrone D. Cannon, Ph.D., all of UCLA’s Semel Institute, will be presented their awards at NARSAD’s 19th annual ceremony in New York City.
Schering-Plough Corporation (NYSE: SGP) reported that the U.S. Food and Drug Administration (FDA) has approved NOXAFIL(R) (posaconazole) Oral Suspension for the treatment of oropharyngeal candidiasis (OPC), including infections refractory to itraconazole and/or fluconazole. OPC is a fungal infection of the mouth and throat caused by the yeast Candida. NOXAFIL is a novel triazole antifungal agent discovered and developed by Schering-Plough Research Institute.
Many people with constipation are confused about the cause of their condition and its appropriate treatment with laxatives. Results of a new large-scale global survey, announced today, show that many people wrongly fear that laxatives are addictive and that their use for long periods of time actually causes constipation.1,2